Production (Stage)
Senti Biosciences, Inc.
SNTI
$3.11
-$0.10-3.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,213.44% | 97.89% | -157.66% | 7.50% | 35.29% |
| Total Depreciation and Amortization | -36.53% | -0.34% | -0.20% | 49.09% | -33.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.34% | -178.20% | 1,758.85% | 12.81% | -126.99% |
| Change in Net Operating Assets | -41.74% | -147.88% | 27.76% | 307.69% | -90.22% |
| Cash from Operations | -4.04% | -71.68% | 5.74% | 28.57% | -66.01% |
| Capital Expenditure | -- | -- | -- | 100.00% | -275.00% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -118.33% | -- | 100.00% | -114.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 490,390.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -118.47% | -7.78% | -- | -- | -- |
| Cash from Financing | -100.81% | 2,002.05% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.29% | 803.97% | 35.70% | 28.66% | -83.34% |